Skip to content
Search AI Powered

Latest Stories

MPs briefed about pharmacies’ unlocked potential in long-term condition prevention

MPs briefed about pharmacies’ unlocked potential in long-term condition prevention

MPs expressed strong agreement with the CPE that the government needs to review pharmacy funding structures  

Community Pharmacy England (CPE) highlighted the untapped potential of community pharmacies in the prevention and management of long-term conditions to Conservative MPs during an event last week.


The roundtable discussion was attended by a select group of influential and supportive MPs alongside community pharmacy owners, the Chief Executive of Community Pharmacy England, the Director of NHS Services, and patient representative group Healthwatch.

MPs in attendance included Steve Double, MP for St Austell and Newquay, who chaired the discussion; Will Quince MP, former Minister for Pharmacy, Derek Thomas MP, Sir Peter Bottomley and Peter Aldous MP.

They talked about the current pressures and funding crisis in community pharmacy, exploring solutions on how this could be eased and the huge benefits that can be unlocked.

CPE Committee members Beran Patel, an independent pharmacy owner, and Jay Patel, Executive Director of Day Lewis, gave their firsthand experiences and perspectives.

Healthwatch also presented its findings on how the public views pharmacies, suggesting that people want pharmacies to offer more services such as vaccinations.

The CPE informed the MPs that community pharmacies can help reduce the burden of long-term conditions if the “current pressures on the sector can be eased.”

CPE CEO Janet Morrison said: “It is critical that we continue to work with MPs to press for solutions to the ongoing intolerable pressures on community pharmacies, but also to show all political parties the very great benefits that pharmacies could offer any new Government if those pressures are addressed.

“This event was another useful way to do that, and it was encouraging to meet with a group of MPs who seemed to so clearly support community pharmacies.

“We’re grateful to Steve Double MP and his parliamentary colleagues for sharing their views and discussing with us what needs to happen to tackle the challenges the sector faces and will be continuing our dialogue with them.”

According to the CPE, the MPs expressed strong agreement with them that the government needs to review “pharmacy funding structures”, and they also demonstrated a keen understanding of the challenges facing frontline pharmacists and pharmacy businesses.

“They agreed that the sector must not be unfairly financially penalised – through fee reductions – for doing too much work,” the CPE said.

During an event last week, the CPE also briefed the Shadow Pharmacy Minister Preet Kaur Gill MP on the need for further investment in the sector.

In their next parliamentary event, scheduled on 12 March, CPE members will be hosting a ‘Model Pharmacy Drop-In’ in partnership with the other national pharmacy organisations.

Pharmacists will be available to demonstrate how they are further helping patients as part of the Pharmacy First service.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less